U.S. FDA nod for Lupin’s copy of Gilead Sciences’ HIV drug
Generic drugmaker Lupin has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Bictegravir, Emtricitabine and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. The tablets are bioequivalent to Gilead Sciences Biktarvy Tablets, 50 mg/200 mg/25 mg and indicated for treatment of human immunodeficiency virus infection in…
Read More “U.S. FDA nod for Lupin’s copy of Gilead Sciences’ HIV drug ” »